Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk

A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 250 participants.

Also called NCT07806279

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07806279
  • EU CT 2026-527136-13-00
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07806279. Randomized; no masking; primary purpose treatment. Start 2026-10-30 (anticipated); primary completion 2030-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Lifestyle Changes, Mushroom Supplementation, and Bupropion to Reduce Adiposity and Cardiometabolic Risk
Condition
Cardiometabolic Syndrome
Condition
Obesity and Cardiovascular Risk
Condition
Overweight , Obesity
Intervention (Drug)
Bupropion 150 mg
Intervention (Dietary supplement)
Lyophilized powder from edible mushrooms
Intervention (Behavioral)
Lifestyle Management
Lead sponsor
Uppsala University (class: other)

Record details

Record id
cardio:ct-nct07806279
Content hash
2f384704be4c4b326b850cdb83d21c4195f6353b5dfc09fbc896f911dc187431